Subject(s)
Stevens-Johnson Syndrome , Adrenal Cortex Hormones/therapeutic use , Anti-Infective Agents/therapeutic use , Bandages , Combined Modality Therapy , Debridement , Dermatologic Agents/therapeutic use , Diagnosis, Differential , Enteral Nutrition , Humans , Hyperbaric Oxygenation , Immunosuppressive Agents/therapeutic use , Plasmapheresis , Stevens-Johnson Syndrome/therapyABSTRACT
Anaemia is common in children following cardiac transplantation. In a series of 5 children with anaemia beyond the immediate post-operative period one had a hypochromic, microcytic anaemia which corrected with oral iron. The other four had normochromic, normocytic anaemias unresponsive to iron or folate supplementation and associated with inappropriately low levels of erythropoietin. Subcutaneous administration of low dose human recombinant erythropoietin to these four patients resulted in correction of their anaemia. Our findings suggest that erythropoietin deficiency is an important cause of anaemia in transplant recipients and should be sought in cases of anaemia refractory to conventional haematinic therapy. In cases of proven erythropoietin deficiency, treatment with erythropoietin is effective, acceptable to patients and preferable to repeated blood transfusion.